Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma

Background: Olfactory neuroblastoma (ONB) is a rare malignancy arising in the nasal vault. Endoscopic resection has been reported to improve overall survival (OS). At present, clinicopathological predictors of the prognosis of ONB remain undefined. Methods: Data including demographics, clinical char...

Full description

Bibliographic Details
Main Authors: Jingyi Yang, Xiaole Song, Yuting Lai, Weidong Zhao, Jiaying Zhou, Quan Liu, Wanpeng Li, Huankang Zhang, Huan Wang, Peng Shi, Hongmeng Yu, Xicai Sun, Dehui Wang
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020303217
id doaj-1f3546a8fa8b4f249ce832807f592d49
record_format Article
spelling doaj-1f3546a8fa8b4f249ce832807f592d492020-12-03T04:32:26ZengElsevierEClinicalMedicine2589-53702020-12-0129100577Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastomaJingyi Yang0Xiaole Song1Yuting Lai2Weidong Zhao3Jiaying Zhou4Quan Liu5Wanpeng Li6Huankang Zhang7Huan Wang8Peng Shi9Hongmeng Yu10Xicai Sun11Dehui Wang12Department of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Nasal and Cranial Surgery, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR ChinaDepartment of Environmental Health, School of Public Health, China Medical University, Shenyang 110000, PR ChinaDepartment of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR China; Research Units of New Technologies of Endoscopic Surgery in Skull Base Tumor, Chinese Academy of Medical Sciences, Shanghai 200031, PR China; Corresponding authors.Department of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR China; Corresponding authors.Department of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, PR China; Corresponding authors.Background: Olfactory neuroblastoma (ONB) is a rare malignancy arising in the nasal vault. Endoscopic resection has been reported to improve overall survival (OS). At present, clinicopathological predictors of the prognosis of ONB remain undefined. Methods: Data including demographics, clinical characteristics and follow-up information of ONB patients treated with endoscopic surgery were collected. Risk factors on OS rates were investigated by LASSO and Cox analyses. A nomogram was developed and evaluated with internal validation. Risk groups were established according to patients’ points in the nomogram. Findings: 154 ONB patients treated with surgery were included in this single center study. A nomogram based on multivariate Cox regression model including multiple tumor history, orbital invasion, carotid canal invasion, modified Kadish stage, delivery sequence of RT and surgery, sequence of chemotherapy and surgery was developed. The bias-corrected C-index (0.886 [95% CI: 0.843-0.943]) was significantly higher than of conventional staging classifications. The AUC of nomogram regarding 1-, 2- and 5-year OS probabilities reached 0.912, 0.929 and 0.957, respectively. The risk levels based on nomogram points were more discriminative than conventional classifications. Interpretation: Validation analysis showed good predictive accuracy and discriminative ability of the nomogram. Therefore, the nomogram could be utilized to individually predict survival probability for ONB patients after endoscopic resection. Funding: This study was funded by the Chinese Academy of Medical Sciences (No. 2019-I2M-5-003), the Shanghai Science and Technology Commission (No. 19411950600), the Shanghai Hospital Development Center (No. SHDC12018118) and the Eye, Ear, Nose and Throat Hospital of Fudan University (No. SYB202006).http://www.sciencedirect.com/science/article/pii/S2589537020303217Olfactory neuroblastomaEndoscopic surgeryOverall survivalNomogram
collection DOAJ
language English
format Article
sources DOAJ
author Jingyi Yang
Xiaole Song
Yuting Lai
Weidong Zhao
Jiaying Zhou
Quan Liu
Wanpeng Li
Huankang Zhang
Huan Wang
Peng Shi
Hongmeng Yu
Xicai Sun
Dehui Wang
spellingShingle Jingyi Yang
Xiaole Song
Yuting Lai
Weidong Zhao
Jiaying Zhou
Quan Liu
Wanpeng Li
Huankang Zhang
Huan Wang
Peng Shi
Hongmeng Yu
Xicai Sun
Dehui Wang
Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
EClinicalMedicine
Olfactory neuroblastoma
Endoscopic surgery
Overall survival
Nomogram
author_facet Jingyi Yang
Xiaole Song
Yuting Lai
Weidong Zhao
Jiaying Zhou
Quan Liu
Wanpeng Li
Huankang Zhang
Huan Wang
Peng Shi
Hongmeng Yu
Xicai Sun
Dehui Wang
author_sort Jingyi Yang
title Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
title_short Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
title_full Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
title_fullStr Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
title_full_unstemmed Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
title_sort development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2020-12-01
description Background: Olfactory neuroblastoma (ONB) is a rare malignancy arising in the nasal vault. Endoscopic resection has been reported to improve overall survival (OS). At present, clinicopathological predictors of the prognosis of ONB remain undefined. Methods: Data including demographics, clinical characteristics and follow-up information of ONB patients treated with endoscopic surgery were collected. Risk factors on OS rates were investigated by LASSO and Cox analyses. A nomogram was developed and evaluated with internal validation. Risk groups were established according to patients’ points in the nomogram. Findings: 154 ONB patients treated with surgery were included in this single center study. A nomogram based on multivariate Cox regression model including multiple tumor history, orbital invasion, carotid canal invasion, modified Kadish stage, delivery sequence of RT and surgery, sequence of chemotherapy and surgery was developed. The bias-corrected C-index (0.886 [95% CI: 0.843-0.943]) was significantly higher than of conventional staging classifications. The AUC of nomogram regarding 1-, 2- and 5-year OS probabilities reached 0.912, 0.929 and 0.957, respectively. The risk levels based on nomogram points were more discriminative than conventional classifications. Interpretation: Validation analysis showed good predictive accuracy and discriminative ability of the nomogram. Therefore, the nomogram could be utilized to individually predict survival probability for ONB patients after endoscopic resection. Funding: This study was funded by the Chinese Academy of Medical Sciences (No. 2019-I2M-5-003), the Shanghai Science and Technology Commission (No. 19411950600), the Shanghai Hospital Development Center (No. SHDC12018118) and the Eye, Ear, Nose and Throat Hospital of Fudan University (No. SYB202006).
topic Olfactory neuroblastoma
Endoscopic surgery
Overall survival
Nomogram
url http://www.sciencedirect.com/science/article/pii/S2589537020303217
work_keys_str_mv AT jingyiyang developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT xiaolesong developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT yutinglai developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT weidongzhao developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT jiayingzhou developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT quanliu developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT wanpengli developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT huankangzhang developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT huanwang developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT pengshi developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT hongmengyu developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT xicaisun developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
AT dehuiwang developmentandvalidationofapostoperativenomogramforpredictingoverallsurvivalafterendoscopicsurgicalmanagementofolfactoryneuroblastoma
_version_ 1724401350580633600